Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential.

AUTOR(ES)

Baron, U

RESUMO

Several tetracycline-controlled transactivators (tTA) were generated which differ in their activation potential by >3 orders of magnitude. The transactivators are fusions between the Tet repressor and minimal transcriptional activation domains derived from Herpes simplex virus protein 16 (VP16). By reducing the VP16 moiety of the previously described tTA to 12 amino acids, potential targets for interactions with various cellular transcription factors were eliminated, as were potential epitopes which may elicit a cellular immune response. When compared with the originally described tTA, these new transactivators are tolerated at higher intracellular concentrations. This will facilitate establishment of tet regulatory systems under a variety of conditions, but particularly when cell type-restricted tetracycline-controlled gene expression is to be achieved in transgenic organisms via homologous recombination.

Documentos Relacionados

• Overreplication and recombination of DNA in higher eukaryotes: potential consequences and biological implications.
• Cytokinesis in Prokaryotes and Eukaryotes: Common Principles and Different Solutions
• Polypeptide chain initiation in eukaryotes: mechanism of formation of initiation complex.
• Polypeptide chain initiation in eukaryotes: initiation factor MP in Artemia salina embryos.
• Polypeptide chain initiation in eukaryotes: reversibility of the ternary complex-forming reaction.